Opera Phenix High Content Screening Imager for NCATS ETB BSL3 Laboratory
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75N95021Q00011
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95021P00044 Federal contract award
- Awardee
- Revvity Health Sciences, Inc.
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- GBR
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice was published by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to award a contract to an unknown vendor for an Opera Phenix High Content Screening Imager for the NCATS ETB BSL3 Laboratory. It was awarded under a class justification and approval for other than full and open competition due to unusual and compelling urgency to facilitate COVID-19 recovery efforts through December 2021, as authorized by 41 U.S.C. 253(c)(1) and FAR 6.302-2 and 16.505(b)(2)(i)(A). The award was made on December 18, 2020 for an unknown dollar amount under contract number 75N95021P00044 to address the COVID-19 pandemic.
Notice text
This contract was awarded under a class Justification and Approval (J&A) and the procedures in FAR subpart 13.5 were used in accordance with 41 U.S.C. 1903 due to Unusual and Compelling Urgency, to facilitate the recovery efforts necessary to address the 2019 Novel Coronavirus (COVID-19). This class J&A is essential to respond to urgent requests for immediate support to respond to the expanding outbreak of COVID-19 which was declared a global pandemic by the WorldHealth Organization (WHO) on March 11, 2020 and a national emergency via a PresidentialProclamation on March 13, 2020. Based upon the Centers for Disease Control and Prevention (CDC) forecasts for COVID-19, this constitutes an unusual and compelling urgency that demands immediate attention. Immediate acquisition of services and supplies will help ensure the United States of America remains prepared for and capable of responding to a public health emergency in the necessary and immediate manner that is required.
Awarded contract 75N95021P00044 to unknown vendor for unknown amount on 2020-12-18.
Files
| File | Type | Posted |
|---|---|---|
| HHS_Class_JnA_Final_3.21.20_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Opera Phenix High Content Screening Imager or Brand Equal for NCATS ETB BSL3 Laboratory | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity